What are the purchasing channels for Sotoraxibu? How much does it cost?

Sotorasib is a new generation of anti-cancer drugs and one of the revolutionary drugs in the field of tumor treatment. Its unique mechanism of action and excellent efficacy make it a new hope for cancer patients.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.

What is unique about this drug is that it is a targeted treatment for KRAS gene mutations. KRASGene mutation is a common cancer driver mutation, especially in tumors such as pancreatic cancer and colorectal cancer. Sotoracib blocks the abnormal proliferation and survival of cancer cells by inhibiting the activity of KRAS gene mutations, thereby achieving therapeutic effects.

This drug has shown remarkable efficacy in clinical trials. Studies have shown that sotoracib not only exhibits encouraging survival benefits in the treatment of patients with advanced tumors, but also reduces cancer patients' symptoms and improves their quality of life. This makes sotorasib stand out in the field of tumor treatment and become one of the highly anticipated innovative drugs.

In addition, the launch of sotoracib has also attracted widespread attention from the medical community. As a targeted therapeutic drug, it not only has high selectivity for cancer cells and reduces damage to normal cells, but also provides a more effective and innovative treatment option for tumor patients. This undoubtedly brings a new dawn to cancer patients and breaks the past frustration with KRAS mutation treatment.